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Abstract
Moxidectin (MOX) is a widely used anthelmintic drug for the treatment of internal and external parasites in food-producing and
companion animals. Transformation products (TPs) of MOX, formed through metabolic degradation or acid hydrolysis, may
pose a potential environmental risk, but only few were identified so far. In this study, we therefore systematically characterized
electro- and photochemically generated MOX TPs using high-resolution mass spectrometry (HRMS). Oxidative electrochemical
(EC) TPs were generated in an electrochemical reactor and photochemical (PC) TPs by irradiation with UV-C light. Subsequent
HRMSmeasurements were performed to identify accurate masses and deduce occurring modification reactions of derived TPs in
a suspected target analysis. In total, 26 EC TPs and 59 PC TPs were found. The main modification reactions were hydroxylation,
(de-)hydration, and derivative formation with methanol for EC experiments and isomeric changes, (de-)hydration, and changes at
the methoxime moiety for PC experiments. In addition, several combinations of different modification reactions were identified.
For 17 TPs, we could predict chemical structures through interpretation of acquired MS/MS data. Most modifications could be
linked to two specific regions of MOX. Some previously described metabolic reactions like hydroxylation or O-demethylation
were confirmed in our EC and PC experiments as reaction type, but the corresponding TPs were not identical to known
metabolites or degradation products. The obtained knowledge regarding novel TPs and reactions will aid to elucidate the
degradation pathway of MOX which is currently unknown.
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Introduction
The veterinary drug moxidectin (MOX) belongs to the
milbemycin subfamily of macrocyclic lactones [1, 2]. The
broad-spectrum antiparasitic agent is widely used to treat
and prevent endo- and ecto-parasitic infections like round-
worms, fluke, and lice. Food-producing animals like cattle,
sheep, goats, and pigs as well as companion animals like cats
and dogs are medicated with MOX. Several metabolic studies
of MOX in various animals have been published so far, con-
cluding in general that MOX is only moderately metabolized
[3–8]. The fecal excretion percentage of unaltered MOX is
reported between 44 and 77% [9] and residues of MOX can
be detected in feces up to 42 days after treatment [10]. In 2017,
the EMA (European Medicines Agency) rated MOX as a per-
sistent, bioaccumulative, and toxic (PBT) substance and con-
cluded that its common usage constitutes potential environ-
mental risks [11]. Consequently, the environmental fate of
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MOX has been characterized by the FDA (Food and Drug
Administration) [12], providing evidence that MOX shows a
high adsorption to soil (logKoc 4.27–4.62) [12] and moderate
water solubility (logKow 4.77) [12]. Rapid environmental
degradation of MOX is obtained by photolysis (half-life in
water 6.8 h), while biodegradation in soils occurs at a moder-
ate speed (half-life 2 months).
The structure of MOX (Fig. 1) is based on a 16-membered
macrocyclic ring fused with a benzofuran and a spiroketal
function. The spiroketal contains a methoxy moiety at C23
and a branched olefinic group at C25 [1, 2].
Twometabolic modifications ofMOX have been described
previously: hydroxylation reaction at the olefin-containing
side chain (C25) or at the methyl groups of C24 or C14
[3–8] and an O-demethylation or the loss of the methoxime
group [5]. Studies suggest that MOX is a rather stable com-
pound. It was found that in cattle only 13% of MOX was
converted into metabolites [2]. The FDA report mentioned at
least 10 degradation products occurring in trace levels, with-
out identification [12]. Awasthi et al. [13] investigated degra-
dation experiments using thermal, base, and acid hydrolysis or
oxidation with hydrogen peroxide and obtained two degrada-
tion products which were characterized as 3,4-epoxy-
moxidectin and 23-keto-nemadectin. In general, metabolites
(formed by biotransformation processes in living organism)
and degradation products (formed by various microbial, biot-
ic, and abiotic environmental processes) can be summarized
as transformation products (TPs) [14]. Knowledge regarding
TPs is important, because they are potentially more harmful,
more toxic, or more persistent compared with their precursor
[15, 16]. TPs of veterinary drugs are possible residues in food-
stuff or in environmental matrices [14, 17], but frequently
occur only at low levels (up to trace levels forMOX) in animal
and environmental samples [17, 18], rendering the identifica-
tion of novel TPs by non-targeted liquid chromatography/
high-resolution mass spectrometry (LC/HRMS) often difficult
[19, 20]. The process to generate transformation products in a
laboratory environment is termed as simulation. For simula-
tion and identification of novel TPs, different laboratory ap-
proaches are used [21], which simulate different chemical
mechanisms like redox or radical-based reactions. Simple re-
dox reactions can be induced by applying a potential in the
cell of an electrochemical reactor. Furthermore, oxidation re-
actions can be simulated by chemically oxidizing agents or
Fenton(-like) reactions. The Fenton reaction generates hy-
droxyl radicals, which initiate the oxidation process.
Photochemically induced oxidation reactions simulate natu-
rally occurring radical reactions by irradiation with light. For
simulation of drug TPs, a widely used instrumental method is
based on the combination of electrochemistry with mass spec-
trometry (EC/MS) [22–24]. The online coupling between EC
cell and MS enables the detection of stable TPs and also tran-
sient species. A broad reaction spectrum can be simulated by
electrochemistry [25], inducing oxidation or reduction reac-
tions dependent on the chosen potential polarity. The absence
of complex matrices in such experiments simplifies TP iden-
tification. Several studies showed that electrochemistry can
simulate cytochrome P450–mediated metabolic reactions of
drug metabolism, which are mostly simple redox reactions
[23, 26]. In contrast, naturally occurring radical reactions
can be simulated using a photochemical (PC) approach.
The lab-scale simulation of PC processes is performed by
irradiation with light of a certain wavelength for a defined time
[27]. Due to the absorption of light by functional groups,
transformation processes are initiated and TPs are formed.
Photochemical irradiation experiments are used to simulate
the environmental degradation by sunlight., To induce more
possible transformation reactions, light of a defined range of
wavelength and high energy, like UV-C light (200–280 nm), is
used in lab simulations.
The aim of this study was to generate, for the first time, TPs
of MOX by electro- and photochemistry in order to simulate
different natural processes such as redox and radical-based
reactions. The focus was placed on the annotation of primarily
new MOX TPs through chromatographic separation and in-
terpretation of their mass spectra (LC-HRMS). Molecular for-
mulas of the TPs, derived from accurate mass determination,
contain information about occurring modification reactions.
Structure prediction was obtained by investigating the MS/
MS fragmentation pattern. The newly found EC and PC TPs
are compared with each other and with MOX metabolites or
degradation products known from literature. Our study results
Fig. 1 Chemical structure of moxidectin (MOX)
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will contribute to understand the still unknown degradation
pathway of MOX.
Material and methods
Chemicals Moxidectin (purity 95.3%, Pharmaceutical
Secondary Standard) was purchased from Sigma-Aldrich
(Steinheim, Germany). Acetonitrile and methanol were pur-
chased fromChemsolute (Renningen, Germany). Ammonium
acetate was purchased from J.T. Baker (Deventer,
The Netherlands) and formic acid from Merck (Darmstadt,
Germany). Ultrapure water was produced by a Purelab Flex
2 system, ELGA Veolia Water Technologies (Celle,
Germany). All standard chemicals were of p.a. grade and all
solvents (acetonitrile, methanol) of LC/MS grade.
Electrochemistry/mass spectrometry The ROXY™ system
(Antec Scientific, Zoeterwoude, The Netherlands) was used
for electrochemical oxidation consisting of a potentiostat and
an electrochemical flow-through cell (μPrepCell, Antec
Leyden, Zoeterwoude, Netherlands). The potentiostat was ful-
ly operated using the Dialogue Elite™ software (Antec
Leyden, Zoeterwoude, The Netherlands) version 2.0.0.81.
Mass voltammograms were recorded by coupling of the elec-
trochemical cell to an electrospray ionization source of a
TripleTOF® 6600 Quadrupole Time-of-Flight (QTOF) mass
analyzer (Sciex, Darmstadt, Germany). Data was acquired
using Analyst® TF1.8.0 including data processing. For
further data processing, in-house scripts using the statisti-
cal working environment R (REF) [28] were applied. The
software Origin 2019 (OriginLab, Northampton, MA,
USA) was used for the graphical representation of the
three-dimensional mass voltammograms. MOX was dis-
solved in acetonitrile and further diluted with a solvent
mixture consisting of methanol:acetonitrile:water (1:1:1;
v/v/v) with 1% formic acid to a final concentration of
30 μM. The MOX-solvent mixture was pumped through
the EC cell by a Legato® 110 dual rate system syringe
pump (KD Scientific, Hollison, MA USA) with a flow
rate of 10 μL/min. The EC cell, a three-electrode arrange-
ment, was equipped with an auxiliary electrode (fully in-
ert polymeric material containing conductive carbon), a
HyREF™ reference electrode (Pd/H2), and a boron-
doped diamond (BDD) working electrode. The working
electrode and auxiliary electrode were separated by two
100-μm spacers. The potential by the potentiostat was
ramped between 0 and 3500 mV with a scan rate of
10 mV/s (continuous scan mode). The working electrode
was activated by a manufacturer-provided pulse cleaning
program (potential E1, + 2 V; potential E2, − 2 V; poten-
tial E3, 0 V; time t1, 1000 ms; time t2, 1000 ms; time t3,
0 ms; continuously change for 5 min) before each
measurement. The experimental parameters for MS detec-
tion are listed in Table 1. Each mass voltammogram was
recorded at least three times to ensure reproducibility.
Also control measurements with the solvent mixture with-
out MOX were performed. In addition to the online EC/
HRMS measurements, aliquots were collected into a
HPLC vial, and then, the mixture was used for further
LC/HRMS measurements.
Photochemistry Awater-cooled quartz laboratory UV reactor
(photoLab batch-M mid volume 250–400 mL, Peschl
Ultraviolet, Mainz, Germany) equipped with a 150-W medi-
um pressure mercury lamp (TQ 150, Heraeus Noblelight,
Hanau, Germany) was used for all UV irradiation experiments
to simulate UV-(C) light (λ > 200 nm). The measured irradi-
ance of the UV-(C) lamp was 140 W/cm2 (distance 8 cm). For
irradiation studies, 200 mL of a 100 μM MOX solution
(water:acetonitrile, 50:50, v/v) was placed in the reactor vessel
and constantly stirred with a magnetic stirring device
(600 min−1). The water-cooling system of the UV reactor
was set to 10 °C. After temperature equilibration, the UV lamp
was activated and samples (1 mL) were collected at 0, 15, 30,
45, 60, 90, 180, and 240 min. All samples were diluted 1:1
with acetonitrile for LC/HRMS analysis (can be omitted) and
the samples were stored in a fridge (4 °C). The experiment
was performed in triplicate.
Liquid chromatography/mass spectrometry LC/HRMS anal-
ysis of electrochemical and photolysis samples was per-
formed with a Agilent 1290 Infinity II UHPLC (Agilent
Technologies, Waldbronn, Germany) connected to an
electrospray ionization source of a TripleTOF® 6600
Quadrupole Time-of-Flight (TTOF) mass analyzer
(Sciex, Darmstadt, Germany). The UHPLC system con-
sists of a 1290 Infinity II multisampler, a 1290 Infinity II
flexible pump, and a 1290 Infinity II multicolumn ther-
mostat. The analytical column was a Luna Omega PS
Table 1 Parameters of the ESI-TripleTOF® for the EC/HRMS
measurements
Experimental parameters
Gas temperature 250 °C
Ion source gas 1 (nitrogen) 25 L/min
Ion source gas 2 (nitrogen) 25 L/min
Curtain gas (nitrogen) 25 L/min
Ion spray voltage floating 5500 V
Mass range parameters
Collision energy 10 V
Declustering potential 80 V
Mass range 100–800 Da
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C18, particle size 5 μm, pore size 100 Å, 250 × 4.6 mm
(Phenomenex, Torrance, CA, USA) and the column oven
was set to 40 °C. For separation, a mobile phase of (A)
acetonitrile and (B) H2O with 5 mM ammonium acetate
and 0.1% formic acid was used. A gradient program was
used starting with 30% (A) for 1 min. Within 10 min,
(A) was raised to 70%. Then, over 15 min, (A) was
raised up to 95%. After maintaining 95% A for 2 min,
it was decreased within 2 min to 30% (A), and then, the
column was re-equilibrated for 10 min. The flow rate of
the mobile phase was 0.8 mL/min and the injection vol-
ume was 5 μL. The conditions for the TTOF are listed in
Table 2, an information-dependent acquisition (IDA) was
included for MS/MS experiments. The LC/HRMS sys-
tem was controlled via Analyst® TF1.8.0 (AB Sciex)
and the data were processed by SciexOS and using in-
house scripts of the statistical working environment R
[28].
The mass accuracy of the used Sciex TTOF is < 2 ppm and
was confirmed via a tuning run before any measurement. To
assign a potential sum formula and chemical structure to a
measured ion mass, all possible sum formulas within 3 ppm
deviation around the respective m/z were calculated, allowing
only the elements C, H, and O, together with N and Na, to
account for adduct formation in the ESI ion source. If more
than one structural proposal remained, a fit of the isotopomer
distribution (sigma value) was used to rank candidates.
Additionally, the modifications in relation to MOX were cal-
culated divided into gain and loss of atoms. Then, the best
suggestion was selected with focus on reasonable gain and
loss groups. MS/MS spectra, which were acquired in IDA
mode, allowed a further inference of structural confirmation




The generation of MOX-derived EC TPs was done by an
electrochemical reactor connected to HRMS. Molecular for-
mulas were assigned to generated TPs based on accurate mass.
The MOX-containing solution was transferred into the elec-
trochemical cell where an electric potential was applied. The
potential was ramped from 0 up to + 3.5 V, thus inducing
oxidation reactions. The generated TPs were directly analyzed
by ESI-HRMS. The first step was to optimize the experimen-
tal conditions like solvent combinations, modifier, and work-
ing electrode materials. The highest number of generated TPs
and best reproducibility were achieved by using the BDD
working electrode and a solvent mixture consisting of
methanol:acetonitrile:water (1:1:1, v/v/v) with 1% formic
acid.
In Fig. 2, a three-dimensional mass voltammogram of
MOX is plotted, presenting the mass spectra against the ap-
plied potential (0 to 3.5 V). The signal intensity of MOX (m/z
640.385) decreases with increasing potential. Simultaneously,
and induced by rising potential, several m/z traces show in-
creasing intensity, indicating possible TPs, 18 of which are
visualized. The maximum intensity is different, as well as
the potential-dependent intensity course. In general, the TP
formation started at a potential around 1 V, exhibited intensity
maxima between 1 and 2 V, and decreased in intensity with
further rising potential. For example, the most intense TP trace
with m/z 656 showed a maximum around 1.5 V and a sharp
intensity drop at 2 V. Other TPs, for example, the TP trace
with m/z of 702, do not drop in intensity after a maximum but
exhibit rather a plateau. Some TP traces are only observable
within a small potential range (i.e., m/z 620 or m/z 729). Here
the maximum intensity is reached, and then, the intensity is
decreased to the initial value. The overall intensity decrease of
the TP traces indicates that at higher potential values, above
2.5 V, MOX is not transformed to further TPs (there were also
no TPs with lower m/z occurring and the MOX signal inten-
sity is stable). A possible reason for this behavior is that MOX
and/or the TPs are going to be degraded by the high potential
value into small fragments which were not detectable with
MS. The higher the potential value is, the more energy is
available for inducing reactions, so degradation is more likely.
Offline EC/HRMS
For further identification and structural proposals of the gen-
erated TPs, LC/HRMS measurements were made of an EC-
generated reaction mixture. The EC conditions were identical
in relation to the online measurements; the MOX-containing
Table 2 Parameters of the ESI-TripleTOF® for the LC/HRMS mea-
surements, including MS/MS experiments
Experimental parameters
Gas temperature 350 °C
Ion source gas 1 (nitrogen) 50 L/min
Ion source gas 2 (nitrogen) 45 L/min
Curtain gas (nitrogen) 45 L/min
Ion spray voltage floating 5500 V
Mass range parameters—MS 1
Collision energy 10 V
Declustering potential 80 V
Mass range 100–800 Da
Mass range parameters—MS 2
Collision energy 40 V
Collision energy spread 20 V
Declustering potential 80 V
Mass range 50–800 Da
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solution was collected in a vial connected to the effluent of the
EC cell. The chromatogram (see Electronic Supplementary
Material (ESM) Fig. S1) of the reaction mix showed many
additional peaks (potential TPs) when compared with the
MOX standard, but of low intensity in general. The 26 most
intense TPs (EC1–EC26) were selected for further character-
ization and are listed in Table 3. Based on the measured accu-
rate mass, sum formulas were calculated, allowing the deduc-
tion of the type of presentMOXmodifications. The evaluation
of the different modification reactions yielded four major clas-
ses: (de-)hydrogenation, (de-)hydration, hydroxylation, and
EC-induced derivative formation with solvents (mostly with
methanol). Most EC TPs arise by addition of atoms (like ox-
ygen) or small molecules (like water) to MOX. Only two EC
TPs, EC21 and EC25, show a lower m/z than MOX; both TPs
show a dehydrogenation (−H). The most common modifica-
tion reaction is the hydroxylation (+O), identified for 15 EC
TPs as either mono-hydroxylation (EC10, EC20), di-
hydroxylation (EC5), or tetra-hydroxylation (EC8). Also,
combinations between hydroxylation and another modifica-
tion reaction are present. Four EC TPs (EC1, EC6, EC7,
EC9) show a hydration (+ H2O) reaction, this reaction occurs
always in combination with another modification reaction like
hydroxylation (EC1 and EC6) or EC-induced derivatives with
methanol (EC7 and EC9). The generation of solvent deriva-
tives is observed for 13 EC TPs, where in 12 cases methanol is
added, and in one case formic acid (EC16). The derivative
formation occurs mostly in combination with dehydrogena-
tion. Often more than a single methanol derivative is visible;
there are cases of generated di-methanol derivatives (EC19,
EC24) or combinations with other modification reactions (like
hydroxylation). The generated solvent derivative TPs are
mostly detected as sodium adducts. Each of the 26 observed
TPs is characterized by a unique combination of measuredm/z
and retention time. Similar m/z observed at different retention
time indicates isomeric TPs. Constitutional (structural) iso-
mers as well as stereoisomers are possible. However, for EC
TPs of MOX, structural isomers are more likely, because most
chemical modifications may occur at different C atoms of
MOX. EC offline measurements yielded two additional
unique m/z compared with EC online (in total 20 vs 18).
These two peaks had been overlooked in online analysis be-
cause they were of low intensity and only 0.04 Da apart from
more abundant TPs (EC3/18, m/z 654.364 and EC26, m/z
654.401). Separation by UPLC allowed the detection of these
peaks. EC3/18 represent a dehydrogenation with hydroxyl-
ation while EC26 was generated by a dehydrogenation with
methylation. Similar behavior is observed for EC4 (m/z
670.359) and EC23 (m/z 670.395), where a dehydrogenation
in combination with (a) di-hydroxylation (EC4) and (b) EC-
induced derivatives with methanol (EC23) is identified. The
structural elucidation is based on the evaluation of taken MS/
MS data; these are compared with the previously described
ESI-MS fragmentation pathway of MOX (displayed in ESM
Fig. S2). After considering the MS/MS data, the two smallest
ESI fragments of MOX are most important for structural elu-
cidation. These two fragments, fragment 1 and fragment 2, are
displayed in Fig. 3a.
Electrochemistry induced modifications occur within two
regions of MOX. The first region comprises the nitrogen atom
Fig. 2 3D mass voltammogram
of MOX. Mass traces (m/z) of the
transformation products of MOX
as [M+H]+ in dependence of the
applied oxidation potential
ramped from 0 to 3.5 V
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of the methoxime group (fragment 1, orange colored at Fig.
3a). The second region comprises the double bonds present in
fragment 2 and is visualized in green. Seven TPs (EC3, EC6,
EC10, EC12, EC19, EC21, EC22) were selected for structural
elucidation, based on their intensity and modification reaction.
The associated MS/MS fragments to the fragmentation path-
way are given in Tables S1–S3 (see ESM). The TP EC10
shows the highest signal intensity and has an accurate mass
of m/z 656.380 which corresponds to a hydroxylation of
MOX. The hydroxylation is identified at fragment 2 and this
results in different possible structures, displayed in Fig. 3b. It
can be assumed that the oxygen is added at a C atom of a
double bond resulting in four possible positions, three at the
conjugated double bonds (C9, C10, C11) and one at the cy-
clohexene ring (C3). After the hydroxylation enols are build
first, but due to keto-enol tautomerism, it is supposed that the
keto form is present. The TP EC20 has the samem/z as EC10,
but the retention time is different, indicating a different struc-
ture. However, the evaluation of the MS/MS data shows
similar results, suggesting a hydroxylation at fragment 2 with-
out further details. Most likely, these two TPs are constitution-
al isomers. The structural proposals of the selected ECvTPs
are presented in Fig. 4. For all TPs, only one proposed struc-
ture is constructed; the additional opportunities described for
the hydroxylated TPs in detail (Fig. 3b) are only marked. Next
to EC10, most proposed structures of Fig. 4 show modifica-
tions at fragment 2 like EC3 (hydroxylation + dehydrogena-
tion), EC6 (hydroxylation + hydration), EC12 (hydroxylation
+ EC-induced methanol derivative), and EC19 (di-methanol
derivative). EC22 is also a generated derivative with two mol-
ecules of methanol, but one molecule of methanol is added at
the nitrogen atom of fragment 1, the other at fragment 2. The
proposed structure of EC21 is based on modifications at frag-
ment 1, the loss of water is placed at the spiroketal, and by
dehydrogenation, a conjugated double-bond system is
formed.
The obtained results show that several different TPs of
MOX are formed by EC experiments applying positive
Table 3 HRMS data of 26 most
intense EC-generated TPs (online
and offline), listed as [M+H]+
TPs, some TPs are detected as
sodium or ammonium adducts.
The intensity is calculated in re-
lation to the occurring MOX sig-







MOX 25.57 640.3849 C37H54NO8
EC1 14.31 715.4146 C37H60N2O10Na +H2O, +O, +NH4, +Na vw
EC2 17.10 750.3698 C39H55N2O11Na +C2HNO3, +Na vw
EC3 18.54 654.3642 C37H52NO9 −2x H, +O vw
EC4 19.10 670.3586 C37H52NO10 −H2, +2x O vw
EC5 19.49 672.3748 C37H54NO10 +2x O vw
EC6 20.02 674.3899 C37H56NO10 +H2O, +O vw
EC7 21.02 729.4302 C38H62N2O10Na −H, +H2O, +OCH3, +NH4,
+Na
vw
EC8 21.19 704.3646 C37H54NO12 +4x O vw
EC9 21.40 729.4302 C38H62N2O10Na −H, +H2O, +OCH3, +NH4,
+Na
w
EC10 22.04 656.3799 C37H54NO9 +O s
EC11 22.23 708.3718 C38H55NO10Na −H, +OCH3, +Na vw
EC12 22.33 688.4061 C38H58NO10 +O, +OCH3, +H w
EC13 22.57 688.4061 C38H58NO10 +O, +OCH3, +H w
EC14 23.14 688.4061 C38H58NO10 +O, +OCH3, +H vw
EC15 23.20 686.3899 C38H56NO10 −H, +OCH3, +O vw
EC16 23.24 740.3622 C38H55NO12Na +2x O, +HCO2, +Na w
EC17 23.39 710.3880 C38H57NO10Na −H, +O, +OCH3, +Na w
EC18 24.03 654.3642 C37H52NO9 −2x H, +O m
EC19 25.15 702.4217 C39H60NO10 +2x OCH3 w
EC20 25.25 656.3798 C37H54NO9 +O w
EC21 25.50 620.3587 C37H50NO7 −2x H, −H2O m
EC22 26.29 724.4037 C39H59NO10Na −2x H, +2x OCH3, +Na m
EC23 26.42 670.3950 C38H56NO9 −H, +OCH3 w
EC24 26.54 702.4217 C39H60NO10 +2x OCH3 w
EC25 27.16 590.3482 C36H48NO6 −H, −H2O, −CH3O w
EC26 27.33 654.4006 C38H56NO8 −H, +CH3 vw
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potentials. However, most TPs are only occurring with a low
intensity, so the conversion rate is low. The found modifica-
tion reactions and predicted structures indicate that MOX can
be degraded and generate various TPs, whereby two regions
are most reactive. This information can be helpful to deter-
mine the metabolic or degradation pathway of MOX.
Photochemistry
Kinetic studies on the photodegradation of MOX were report-
ed by the FDA [1, 12], reporting a half-life value of 6.8 h in
water. Several photodegradation products were found but
remained unidentified. Here, we performed the photolysis of
MOX, dissolved in water:acetonitrile (50:50), using an UV-C
light reactor. Samples were taken at defined intervals within
the whole process of 240 min and analyzed by LC-HRMS
afterwards. Resulting chromatograms are shown in ESM
Fig. S3.
At the beginning (0 min irradiation), only the MOX peak is
present. After 15 min, several new peaks (PC TPs) can be
detected. After longer irradiation times, the MOX peak is
more and more decreased, and further PC TPs are occurring.
Fig. 3 a Two small known/used fragments of the ESI fragmentation (see
ESM Fig. S2) of MOX are displayed and named as fragment 1 and
fragment 2. Due to evaluation of MS/MS data of the TPs, two regions
of MOX, based on fragment 1 and fragment 2, are identified, where the
modifications are occurring. The regions are marked in orange (nitrogen
atom) and green (fragment 2). b Example of EC10, the hydroxylation
(+O, red colour) of MOX is occurring at fragment 2 and four different C
atoms (C3, C9, C10, C11) are possible. All structural possibilities are
displayed as keto form
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In total, 59 PC TPs are found (ESM Table S4), whereby 19
unique m/z are identified. Selected PC TPs, based on the dif-
ferent m/z, are listed in Table 4.
In general, a huge variety of modification reactions is
identified (see Table 4), but predominant modification re-
actions cannot be found. Most PC TPs (20, PC13–PC33)
have a m/z of 640.385, identical to MOX. This means, by
photolysis, a lot of isomers like stereoisomers (enantiomer
or also diastereomer) are built. Also, hydration (+H2O)
TPs (PC8–PC12) with m/z of 658.395 and dehydration
(−H2O) TPs (PC37–PC48) with m/z of 622.374 are occur-
ring frequently. Here, next to stereoisomers, also consti-
tutional isomers can occur. Whereas constitutional
isomers can be differentiated by mass spectrometry, enan-
tiomeric and diastereomeric differences cannot be identi-
fied easily with mass spectrometry. Five more m/z ratios
are occurring twofold. Structural proposals of selected PC
TPs (different m/z ratios) are displayed in Fig. 5. Here the
stereochemical information is not displayed, because all
stereocenter of MOX can be changed due to irradiation.
For elucidation, associated MS/MS fragments are collated
to the fragmentation pathway (given in Tables S5–S8 in
ESM). As described in Fig. 3b, modifications at fragment
2, like (de-)hydration or hydroxylation can be occurring at
different equivalent positions, and similar to the presented
EC TPs , on ly one s t ruc ture i s d i sp layed . The
Fig. 4 Proposed structures of the TPs derived from EC experiments with MOX using BDD electrode. The x-position marks C atoms, where the
modification (hydroxylation, hydration, or solvent derivates) can be instead of the shown version
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modifications of TPs PC7 (di-hydroxylation), PC12 (hy-
dration), and PC38 (dehydration) are proposed at frag-
ment 2. Modifications at the methoxime group are differ-
ent, including total elimination (PC52) or the loss of
methanol (PC50). The O-demethylation is occurring for
PC35 (in combination with hydrogenation) and for PC54
(in combination with a dehydrogenation at fragment 2).
Further modifications at fragment 1 include hydration at
the nitrogen atom (PC5) or the loss of the olefin-
containing chain including the oxygen (PC57 and PC59).
Analysis of the annotated TP structures reveals that most
modifications are occurring at the methoxime group of MOX,
and most (de-)hydration reactions are occurring at fragment 2.
Similar to PC57 and PC59, two further TPs (PC55 and PC56)
show losses of the olefin-containing chain, but without dehy-
dration. As result, most PC TPs are stereoisomers, and then,
hydroxylated and dehydroxylated TPs are occurring in higher
amounts.
While TPs may show potential differences in ionization
behavior, we assume that these differences are moderate and
characterized TP signal intensities relative to MOX signal. To
this end, six TPs showed a strong intensity (> 15% of the
MOX starting intensity), 11 TPs showed a moderate intensity
(3–15% of MOX), 25 TPs showed a weak intensity (1–3% of
MOX), and 18 TPs were occurring with a very weak intensity
(< 1% of MOX).
PC TPs can be assigned to three different groups (A, B,
C) according to their (irradiation) time-dependent intensity
pattern, illustrated in ESM Fig. S4 for selected PC TPs.
Group A (ESM Fig. S4a) contains PC TPs, which reach a
maximum in intensity at an irradiation time of 15 min,
followed by a sharp decrease. This is the smallest group
and most associated PC TPs are MOX stereoisomers
(PC13–PC33, except PC18, PC22–25). Only a low energy
impact is necessary to induce stereochemical changes which
can be followed by further transformation reactions. The
largest group of PC TPs (B, ESM Fig. S4b, d, e) shows
intensity maxima at irradiation times from 45 to 90 min.
Group B contains all PC TPs (PC1 to PC7) with higher
m/z than MOX (except the hydration TPs, PC8–PC12),
some MOX stereoisomers, and a few PC TPs with smaller
m/z than MOX. Group C (ESM Fig. S4c, f) contains several
PC TPs which show a constant intensity increase or which
reach an intensity plateau with increasing irradiation time.
Most PC TPs of group C show a lower m/z than MOX (e.g.,
PC35 to PC52). Also, the hydration PC TPs (PC8–PC12)
belong to group C. PC TPs of this group are stable (over the
experimental time range) and there is no or only slow deg-
radation visible. In conclusion, stereoisomers of MOX
(group A) are generated fast by low energy impact but are
then quickly transformed. PC TPs of group B are built
slower and show a moderate stability. The formation of PC
TPs of group C needs more energy and the resulting PC TPs
show the highest stability. In general, PC TPs which are
smaller than MOX (group C) are more stable than PC TPs
which are larger than MOX (group B).
Table 4 Resulting PC TPs of
MOX by irradiation experiments,
summarized in groups by
determined modification/sum for-
mula. The accurate mass is
representing the mass of the [M+
H]+ peaks of the TPs (some TPs
are detected as sodium or ammo-
nium adducts)
Compound Amount calc. m/z Molecular formula Suggested modification
MOX 640.3849 C37H54NO8
PC1 699.4196 C37H60N2O9Na +H2O, +Na, +NH4
PC2 694.3567 C37H53NO10Na −H, +2x O, +Na
PC3 685.4404 C37H62N2O8Na +4x H, +Na, +NH4
PC4 681.4091 C37H58N2O8Na +Na, +NH4
PC5/PC6 2 680.3775 C37H55NO9Na −H, +H2O, +Na
PC7 672.3748 C37H54NO10 +2x O
PC8–PC12 5 658.3955 C37H56NO9 +H2O
PC13–PC33 21 640.3849 C37H54NO8
PC34 636.3536 C37H50NO8 −4x H
PC35–PC36 2 628.3849 C36H53NO8 −OCH3, +H, +H2O
PC37–PC48 12 622.3744 C37H52NO7 −H2O
PC49 612.3900 C36H54NO7 −CO
PC50–PC51 2 608.3587 C36H50NO7 −H, −OCH3
PC52 593.3478 C36H49O7 −2x H, −NOCH3
PC53–PC54 2 590.3482 C36H48NO6 −2x H2O, −OCH3, +OH
PC55 558.3345 C32H47NO7 −C5H7O
PC56 532.3189 C30H46NO7 −C7H8O
PC57 514.3083 C30H44NO6 −H2O, −C7H8O
PC58–PC59 2 510.2770 C30H40NO6 −H2O, −C7H12O
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Comparison
A broad range of different modified TPs of MOX are identi-
fied by EC and PC experiments. Furthermore, a Fenton-like
reaction was tested, but no TPs of MOX are occurring (results
not shown). In total, 85 unique TPs are found. It could be
shown that for both experiments, the same modification reac-
tions are occurring; these are summarized in Table 5. The
modification reactions are occurring at the same regions of
MOX, indicated in Fig. 3a as fragment 1 (nitrogen atom)
and fragment 2. The EC TPs showed mostly methoxy deriv-
ative formation at the methoxime group (as a follow of the
electrochemical reaction of MOX with solvent methanol) and
the hydration or hydroxylation were placed at fragment 2. The
PC TPs showed similar results, whereby (de-)hydration mod-
ifications are occurring at fragment 2 and most other
Fig. 5 Predicted structures of selected PC TPs. The x-positions marks equivalent positions of modifications at fragment 2. The y marks the second OH
group for dehydration
Kotthoff L. et al.3150
modification reactions at fragment 1, preferably at the
methoxime group. The TPs EC5 and PC7 show the same
modification reaction, a di-hydroxylation. However, the reten-
tion time of both TPs is different, and MS/MS data confirmed
only that both modifications are occurring at fragment 2.
Hence, EC5 and PC7 might present constitutional isomers.
The known metabolites are mainly mono-hydroxylated spe-
cies. The samemodification reaction is found by electrochem-
istry, but the further structural elucidation showed that the
hydroxylation is occurring at fragment 2 of MOX instead of
positions of fragment 1. Awasthi et al. [13] also found 2,3-
epoxy-moxidectin, a hydroxylated degradation product.
However, epoxides are poorly generated by electrochemistry,
which is probably why we did not detect 2,3-epoxy-
moxidectin. Afzal et al. [5] described three metabolites with
changes in the methoxime moiety. In two metabolites, the
methoxime group is replaced by a ketoxy group, one metab-
olite is additionally hydroxylated, and the third metabolite
exhibits an O-demethylation in combination with a hydroxyl-
ation. The photochemical TPs PC35 and PC54 showed the
same O-demethylation but instead of hydroxylation, other
modification reactions are occurring (hydrogenation, di-dehy-
dration). So, both methods simulate single modification reac-
tions, which are occurring at the metabolic degradation path-
way of MOX, but identical TPs are not found. The compari-
son of TPs found in this study with metabolites of MOX
known from the literature showed no exact match; other en-
vironmental degradation products are unknown. Further envi-
ronmental screenings with respect to MOX residues are nec-
essary to better assess the laboratory results. The 85 TPs found
in this study will be helpful to identify degradation products
by environmental screenings, because of their rather low con-
centrations in organic matter. Especially the PC TPs identified
for the first time could be relevant as environmental degrada-
tion products. The successful simulation of known metabolic
modification reactions like hydroxylation indicates that some
of the generated TPs may also be formed in natural processes
(metabolic or environmental degradation).
Conclusions
This study aimed to generate TPs from MOX by electro- and
photochemical transformation and elucidate their chemical
structure. A total number of 26 EC TPs was found
representing 20 unique m/z ratios and 59 PC TPs representing
19 unique m/z ratios. The major modification reactions of the
EC-generated TPs are (de-)hydrogenation, (de-)hydration, hy-
droxylation, and derivative formation with solvent. Most PC
TPs showed only changes in the stereochemistry (same accu-
rate mass asMOX); additionally major reactions are hydration
and dehydration. Also, several modifications are identified,
mainly hydroxylation and changes at the methoxime group.
Both modification reactions are received by EC or PC exper-
iments, so observed TPs are potentially relevant metabolic or
environmental degradation products. In total, we predicted
chemical structures for 17 EC TPs and PC TPs, based on
accurate mass and additional MS/MS data. The modifications
are located at two regions of MOX, for both experiments. The
identified TPs give a first insight into the degradation pathway
of MOX and can serve as a basis for future toxicity or phys-
icochemical studies. Furthermore, the results can be helpful to
increase the residue analysis of MOX in real samples obtained
from foodstuff, environment, or waste treatment effluents.
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